Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury.
<h4>Objective</h4>Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) play a role in neuroinflammation after brain trauma injury (TBI). Previous studies with small sample size have reported higher circulating MMP-2 and MMP-9 levels in patients with...
Main Authors: | Leonardo Lorente, María M Martín, Patricia López, Luis Ramos, José Blanquer, Juan J Cáceres, Jordi Solé-Violán, Jorge Solera, Judith Cabrera, Mónica Argueso, Raquel Ortiz, María L Mora, Santiago Lubillo, Alejandro Jiménez, Juan M Borreguero-León, Agustín González, Josune Orbe, José A Rodríguez, José A Páramo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24728097/?tool=EBI |
Similar Items
-
High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients
by: Leonardo Lorente, et al.
Published: (2019-07-01) -
Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio.
by: Leonardo Lorente, et al.
Published: (2014-01-01) -
Matrix Metalloproteinases in Diabetic Kidney Disease
by: Nuria Garcia-Fernandez, et al.
Published: (2020-02-01) -
Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients
by: Leonardo Lorente, et al.
Published: (2019-12-01) -
Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.
by: Leonardo Lorente, et al.
Published: (2015-01-01)